Stock Information
BioCryst Pharmaceuticals Inc (BCRX)
Ticker Symbol: BCRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,151.87 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -1.7765
Revenue (TTM): $3.66 M
Dividend Yield: N/A%
ROE: -328.82%
Latest News
-
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
Wed, May 27, 2026 11:00 AM
-
BioCryst Pharma To Present Seven Abstracts From Hereditary Angioedema Portfolio At Annual Meeting Of EAACI 2026
Wed, May 27, 2026 7:25 AM
Key Financials
Financial data not available
